Talitckii Aleksandr, Mangal Joslyn L, Colbert Brendon K, Acharya Abhinav P, Peet Matthew M
IEEE J Biomed Health Inform. 2023 Oct 26;PP. doi: 10.1109/JBHI.2023.3327230.
The immune response is a dynamic process by which the body determines whether an antigen is self or nonself. The state of this dynamic process is defined by the relative balance and population of inflammatory and regulatory actors which comprise this decision making process. The goal of immunotherapy as applied to, e.g. Rheumatoid Arthritis (RA), then, is to bias the immune state in favor of the regulatory actors - thereby shutting down autoimmune pathways in the response. While there are several known approaches to immunotherapy, the effectiveness of the therapy will depend on how this intervention alters the evolution of this state. Unfortunately, this process is determined not only by the dynamics of the process, but the state of the system at the time of intervention - a state which is difficult if not impossible to determine prior to application of the therapy. To identify such states we consider a mouse model of RA (Collagen-Induced Arthritis (CIA)) immunotherapy; collect high dimensional data on T cell markers and populations of mice after treatment with a recently developed immunotherapy for CIA; and use feature selection algorithms in order to select a lower dimensional subset of this data which can be used to predict both the full set of T cell markers and populations, along with the efficacy of immunotherapy treatment.
免疫反应是一个动态过程,通过该过程身体确定抗原是自身的还是非自身的。这一动态过程的状态由构成该决策过程的炎症和调节因子的相对平衡及数量来定义。那么,应用于例如类风湿性关节炎(RA)的免疫疗法的目标,就是使免疫状态偏向调节因子——从而在反应中关闭自身免疫途径。虽然有几种已知的免疫疗法方法,但治疗的有效性将取决于这种干预如何改变这种状态的演变。不幸的是,这个过程不仅由该过程的动态决定,还由干预时系统的状态决定——这种状态在应用治疗之前即便不是不可能确定,也是很难确定的。为了识别这样的状态,我们考虑RA的小鼠模型(胶原诱导性关节炎(CIA))免疫疗法;收集用最近开发的针对CIA的免疫疗法治疗后小鼠的T细胞标志物和群体的高维数据;并使用特征选择算法来选择该数据的低维子集,该子集可用于预测全套T细胞标志物和群体以及免疫疗法治疗的疗效。